Article thumbnail

Bone Marrow-Derived Mesenchymal Stem Cells Ameliorate Hepatic Ischemia Reperfusion Injury in a Rat Model

By Hiroyuki Kanazawa, Yasuhiro Fujimoto, Takumi Teratani, Junji Iwasaki, Naoya Kasahara, Kouji Negishi, Tatsuaki Tsuruyama, Shinji Uemoto and Eiji Kobayashi
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3084802
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1998). A new and simple technique of total hepatic ischemia in the mouse.
  2. (2010). Activation of interleukin-6-induced glycoprotein 130/signal transducer and activator of transcription 3 pathway in mesenchymal stem cells enhances hepatic differentiation, proliferation, and liver regeneration.
  3. (2007). Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes.
  4. (2001). Critical graft size in adult-to-adult living donor liver transplantation: impact of the recipient’s disease. Liver transpl 7:
  5. (2005). Development of new inbred transgenic strains of rats with LacZ or GFP.
  6. (2009). Fibrogenic Potential of Human Multipontent Mesenchymal Stromal Cells in Injured Liver.
  7. (2006). Firefly rats’’ as an organ/ cellular source for long-term in vivo bioluminescent imaging.
  8. (2004). Gene therapy for organ grafts using rapid injection of naked DNA: application to the rat liver.
  9. (2005). Gene transfer to the rat kidney in vivo and ex vivo using an adenovirus vector: factors influencing transgene expression.
  10. (2005). Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion.
  11. (2008). IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury.
  12. (1997). In situ splitting of the cadaveric liver for transplantation.
  13. (2008). Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo.
  14. (2007). Mesenchymal Stem Cell-Derived Molecules Reverse Fulminant Hepatic Failure.
  15. (2008). Mesenchymal stem cells effectively reduce surgically induced stenosis in rat carotids.
  16. (1999). Multilineage potential of adult human mesenchymal stem cells.
  17. (2006). Position Paper Minimal criteria for defining multipotent mesenchymal stromal cells. The international Society for Cellular Therapy position statement.
  18. (2009). Roles of Wnt/beta-catenin signaling in epithelial differentiation of mesenchymal stem cells.
  19. (1996). Splitliver transplantation. The Paul Brousse policy.
  20. (2007). Stem cell plasticity: Learning from hepatogenic differentiation strategies.
  21. (1976). Studies on the cause of death after permanent and temporary occlusion of the portal vein in rats.
  22. (1991). The beneficial effet of a prostaglandin I2 analog on ischemic rat liver.
  23. (2009). The therapeutic potential of human umbilical mesenchymal stem cells from Wharton’s jelly in the treatment of rat liver fibrosis.
  24. (2006). Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats.
  25. (2009). Toward MSC in solid organ transplantation:
  26. (2011). Transplanted Human Amniotic MembraneDerived Mesenchymal Stem Cells Ameliorate Carbon Tetrachloride-Induced Liver Cirrhosis in Mouse.